BioCentury
ARTICLE | Clinical News

Dara BioSciences preclinical data

July 20, 2009 7:00 AM UTC

In diet-induced obese mice, DB959 resulted in a weight gain that was significantly lower than Avandia rosiglitazone from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK, London, U.K.) and similar to vehicle ...